IP Library › Granted Patent US 12,268,838
Granted Patent B2
US 12,268,838 · App. 18/358,147 · Granted Apr 8, 2025

Activation system and method for on-body medical devices

Inventors: Charles George Hwang (Wellesley, MA); J. Richard Gyory (Sudbury, MA); Joseph Gordon (Mansfield, MA); Kenneth Focht (Needham, MA); Stanislav Torgovitsky (Washington, DC); Stacey J. Longanecker (Glenn Dale, MD)
Assignee: Becton, Dickinson and Company
A61M5/14248A61M5/16831G16H40/63G16Z99/00A61M2005/16863A61M2205/276A61M2205/3386A61M2205/3584A61M2205/50A61M2205/502A61M2205/582A61M2205/8206
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,268,838
App. No.
18/358,147
Granted
Apr 8, 2025
Kind
B2
Abstract

A medical device for infusing medical substances has activation buttons accessible on an exterior of a device housing. The activation buttons and corresponding electrical switches within the device housing are configured to prevent inadvertent activation of the activation buttons and therefore inadvertent operation of the corresponding electrical switches to initiate a process such as the infusion of medical substance(s) to a user. The medical device employs overlap of respective time traces initiated by activation of the activation buttons to determine whether the activation is intended and valid. These respective time traces do not have to be initiated simultaneously or in any particular sequence. The activation buttons can be elastomeric overmolded buttons set within cutouts in the device housing, and, when depressed, make physical contact with the corresponding electrical switches.

Claims (19)

1. A method for infusing a medical substance, the method comprising:

initiating a first time trace based on a first user input and a second time trace based on a second user input, the first time trace and the second time trace being independent time traces based on said first user input and said second user input, said first time trace comprising a first start time, a first stop time, and a first duration, said second time trace comprising a second start time, a second stop time, and a second duration;

evaluating said first time trace and said second time trace to command a designated operation of a medical device based on a comparison between said first time trace and said second time trace, said comparison depending on at least one of said first start time, said first stop time, and said first duration, coinciding with at least one of said second start time, said second stop time, and said second duration; and

initiating the designated operation of the medical device when the comparison between said first time trace and said second time trace indicates a valid activation using said first user input and said second user input, wherein the designated operation of the medical device is independent of the first duration and the second duration.

2. The method of claim 1 , further comprising:

receiving said first user input via a first user accessible activation control; and

receiving said second user input via a second user accessible activation control

wherein said initiating of said first time trace and said second time trace comprises

selectively initiating said first time trace based on said first user accessible activation control receiving said first user input; and

selectively initiating said second time trace based on said second user accessible activation control receiving said second user input.

3. The method of claim 2 , wherein

said first user accessible activation control comprises a first user accessible button,

said second user accessible activation control comprises a second user accessible button, and

said first user accessible button and said second user accessible button are configured with respect to a housing.

4. The method of claim 3 , wherein said housing comprises a volume containing said medical substance, and the designated operation of the medical device comprises initiating the infusing of the medical substance at a designated time following a determination of the valid activation.

5. The method of claim 3 , wherein said first user accessible button is disposed at a distance with respect to said second user accessible button, whereby actuation of said first user accessible button is independent of actuation of said second user accessible button.

6. The method of claim 1 , wherein any one of said first stop time, said first duration, said second start time, said second stop time, and said second duration comprises at least one of a preset value stored in a non-transient computer readable memory, a value transmitted to a controller via wired and/or wireless communication, and a selectively determined value based on an intended operation of the medical device.

7. The method of claim 1 , further comprising initiating a first timer in response to said first user input, and initiating a second timer in response to said second user input, said first time trace and said second time trace corresponding to a duration of the first timer and a duration of the second timer, respectively.

8. The method of claim 7 , wherein the initiating the designated operation of the medical device comprises determining when the duration of the first timer and the duration of the second timer overlap, the comparison between said first time trace and said second time trace corresponding to the overlap.

Continuity (4)
Continuation 17542218 · Dec 3, 2021
Division 15506923
Provisional Application 62048733 · Sep 10, 2014
Related Publication 20230364330A1 · Nov 16, 2023
References Cited (69)
US 3668337A · Sinclair · 1972 [cited by applicant]
US 4349712A · Michalski · 1982 [cited by applicant]
US 4766271A · Mitsuhashi et al. · 1988 [cited by applicant]
US 5136131A · Komaki · 1992 [cited by applicant]
US 5399823A · McCusker · 1995 [cited by applicant]
US 5665065A · Colman et al. · 1997 [cited by applicant]
US 6093900A · Wisskirchen et al. · 2000 [cited by applicant]
US 6603086B2 · Kawaguchi et al. · 2003 [cited by applicant]
US 6747446B1 · Voisine et al. · 2004 [cited by applicant]
US 6841748B2 · Serizawa et al. · 2005 [cited by applicant]
US 7094985B2 · Kobayashi et al. · 2006 [cited by applicant]
US 7435922B1 · Wittig et al. · 2008 [cited by applicant]
US 7708717B2 · Estes et al. · 2010 [cited by applicant]
US 7771391B2 · Carter · 2010 [cited by applicant]
US 7884295B2 · Aoki et al. · 2011 [cited by applicant]
US 7922708B2 · Estes et al. · 2011 [cited by applicant]
US 8062253B2 · Nielsen et al. · 2011 [cited by applicant]
US 8008591B2 · Shi et al. · 2011 [cited by applicant]
US 8094806B2 · Levy · 2012 [cited by applicant]
US 8114064B2 · Alferness et al. · 2012 [cited by applicant]
US 8184023B2 · Naka et al. · 2012 [cited by applicant]
US 8226606B2 · Adams et al. · 2012 [cited by applicant]
US 8226607B2 · Carter et al. · 2012 [cited by applicant]
US 8231572B2 · Carter et al. · 2012 [cited by applicant]
US 8242922B2 · Varasteh · 2012 [cited by applicant]
US 8263889B2 · Takahashi et al. · 2012 [cited by applicant]
US 8267921B2 · Yodfat et al. · 2012 [cited by applicant]
US 8414563B2 · Kamen et al. · 2013 [cited by applicant]
US 8455778B2 · Yang et al. · 2013 [cited by applicant]
US 8469920B2 · Mernoe et al. · 2013 [cited by applicant]
US 8540673B2 · Hines et al. · 2013 [cited by applicant]
US 8653392B2 · Berger et al. · 2014 [cited by applicant]
US 8810438B2 · Tsai et al. · 2014 [cited by applicant]
US 8894632B2 · Yodfat et al. · 2014 [cited by applicant]
US 9192713B2 · Yodfat et al. · 2015 [cited by applicant]
US 11752257B2 · Hwang · 2023 [cited by examiner]
US 20020092753A1 · Asada · 2002 [cited by applicant]
US 20030160683A1 · Blomquist · 2003 [cited by applicant]
US 20090065342A1 · Yoon et al. · 2009 [cited by applicant]
US 20090237275A1 · Vaganov · 2009 [cited by applicant]
US 20090247982A1 · Krulevitch et al. · 2009 [cited by applicant]
US 20090281497A1 · Kamen et al. · 2009 [cited by applicant]
US 20110022025A1 · Savoie et al. · 2011 [cited by applicant]
US 20110319862A1 · Friedman et al. · 2011 [cited by applicant]
US 20110320184A1 · Beyer et al. · 2011 [cited by applicant]
US 20120061226A1 · Edo et al. · 2012 [cited by applicant]
US 20120215175A1 · Alferness et al. · 2012 [cited by applicant]
US 20120253262A1 · Lemke · 2012 [cited by examiner]
US 20130072872A1 · Yodfat · 2013 [cited by examiner]
US 20130114195A1 · Lee · 2013 [cited by applicant]
US 20140088504A1 · King · 2014 [cited by applicant]
US 20140262715A1 · Lee et al. · 2014 [cited by applicant]
US 20160000366A1 · Jensen · 2016 [cited by applicant]
US 20170239415A1 · Hwang et al. · 2017 [cited by applicant]
CN 103394143A · 2013 [cited by applicant]
CN 103415310A · 2013 [cited by applicant]
CN 103477314A · 2013 [cited by applicant]
EP 3191155A1 · 2017 [cited by applicant]
GB 2234115A · 1991 [cited by applicant]
JP 6440793 · 1989 [cited by applicant]
JP 01183022A · 1989 [cited by applicant]
JP 06231652A · 1994 [cited by applicant]
JP 6678654B2 · 2020 [cited by applicant]
WO 2012108723A2 · 2012 [cited by applicant]
WO 2016040423A1 · 2016 [cited by applicant]
Canadian Office Action dated Apr. 16, 2021, which issued in the corresponding Canadian Patent Application No. 2,960,223. [cited by applicant]
Chinese of Office Action dated Mar. 18, 2020, which issued in the corresponding Chinese Patent Application No. 201580052982.1, including English translation. [cited by applicant]
English translation of the Japanese Office Action dated Jul. 2, 2019, which issued in the corresponding Japanese Patent Application No. 2017-513452. [cited by applicant]
Chinese Office Action dated Feb. 19, 2019, which issued in corresponding Chinese Patent Application No. 201580052982.1, including English translation. [cited by applicant]